Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
Xiaoqing Luo, Enze Zheng, Wei Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Lipid alterations in chronic liver disease and liver cancer
Bichitra Paul, Monika Lewińska, Jesper B. Andersen
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100479-100479
Open Access | Times Cited: 198
CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis
Ping Yang, Hong Qin, Yiyu Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 160
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 123
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
Emerging targets in lipid metabolism for cancer therapy
Alexander R. Terry, Nissim Hay
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 537-551
Open Access | Times Cited: 21
Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment
Yuze Hua, Sen Yang, Yalu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 19
Apolipoprotein C‐II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway
Chao Wang, Zhi Yang, En Xu, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 92
CD36 favours fat sensing and transport to govern lipid metabolism
Yunxia Li, Xingguo Huang, Guan Yang, et al.
Progress in Lipid Research (2022) Vol. 88, pp. 101193-101193
Closed Access | Times Cited: 66
CD36: an emerging therapeutic target for cancer and its molecular mechanisms
Chengwei Ruan, Yankai Meng, Song Hu
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 7, pp. 1551-1558
Closed Access | Times Cited: 54
Role of CD36 in cancer progression, stemness, and targeting
Sandra Guerrero-Rodríguez, Cecilia Mata-Cruz, Sonia Mayra Pérez‐Tapia, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 53
The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target
William W. Feng, Hannah Zuppe, Manabu Kurokawa
Cells (2023) Vol. 12, Iss. 12, pp. 1605-1605
Open Access | Times Cited: 37
LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2
Fan Wang, Yuhang Hu, Hongda Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 28
CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury
Yixin Ma, Lili Huang, Zheng Zhang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 449-463
Open Access | Times Cited: 25
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming
Ting Yu, Zhaoyun Liu, Qingxu Tao, et al.
Cancer Letters (2024) Vol. 589, pp. 216824-216824
Open Access | Times Cited: 12
Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells
Shi Zheng, Cuilan Hu, Xiaogang Zheng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 12
Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression
Yuxuan Yang, Xiaokun Liu, Di Yang, et al.
Metabolism (2024) Vol. 155, pp. 155905-155905
Closed Access | Times Cited: 11
New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma—Today and Tomorrow
Rafał Becht, Kajetan Kiełbowski, Michał Wasilewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1456-1456
Open Access | Times Cited: 10
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 10
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC
Tuo Deng, Jungang Zhao, Yifan Tong, et al.
Oncogene (2024) Vol. 43, Iss. 13, pp. 944-961
Closed Access | Times Cited: 9
APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway
Qi Wang, Bingyu Wang, Wenjing Zhang, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 755, pp. 109983-109983
Open Access | Times Cited: 9
Polystyrene nanoplastics promote colitis-associated cancer by disrupting lipid metabolism and inducing DNA damage
Shan Tian, Ruixue Li, Jiao Li, et al.
Environment International (2025) Vol. 195, pp. 109258-109258
Open Access | Times Cited: 1
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism
Chun‐Cheng Yang, Yu‐Chuan Yan, Guo‐Qiang Pan, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics
Yuanjie Liu, Shuhong Zeng, Wei Zhang, et al.
Pharmacological Research (2023) Vol. 188, pp. 106644-106644
Open Access | Times Cited: 22
OXPHOS inhibitors, metabolism and targeted therapies in cancer
Octavia Cadassou, Lars Petter Jordheim
Biochemical Pharmacology (2023) Vol. 211, pp. 115531-115531
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top